Jorge M. Gomez - 09 May 2022 Form 3 Insider Report for Moderna, Inc. (MRNA)

Role: Officer
Signature: /s/ Brian Sandstrom, As Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 09 May 2022
Net transactions value: $0
Form type: 3
Filing time: 11 May 2022, 16:23:50 UTC
Previous filing: 11 Apr 2022
Next filing: 12 May 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

The reporting person was appointed Chief Financial Officer of the Issuer on May 9, 2022 but departed the Issuer on May 10, 2022 as reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission on May 11, 2022.